Maven Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,370
Closed -$3.4M 893
2025
Q1
$3.61M Sell
4,370
-101
-2% -$84K 0.11% 176
2024
Q4
$3.45M Buy
4,471
+1,586
+55% +$1.31M 0.08% 191
2024
Q3
$2.56M Sell
2,885
-670
-19% -$602K 0.05% 307
2024
Q2
$3.22M Sell
3,555
-3,234
-48% -$2.59M 0.07% 271
2024
Q1
$5.28M Buy
6,789
+4,113
+154% +$2.93M 0.31% 37
2023
Q4
$1.56M Buy
+2,676
New +$1.56M 0.03% 368
2023
Q3
Sell
-2,180
Closed -$1.12M 1174
2023
Q2
$1.02M Buy
+2,180
New +$914K 0.02% 440
2023
Q1
Sell
-1,902
Closed -$641K 1005
2022
Q4
$696K Buy
1,902
+611
+47% +$217K 0.02% 500
2022
Q3
$417K Buy
1,291
+18
+1% +$5.7K 0.01% 846
2022
Q2
$413K Buy
+1,273
New +$382K 0.01% 645
2022
Q1
Sell
-994
Closed -$256K 1050
2021
Q4
$275K Sell
994
-247
-20% -$62.6K 0.01% 708
2021
Q3
$287K Buy
+1,241
New +$306K 0.01% 850
2021
Q2
Sell
-1,058
Closed -$213K 1197
2021
Q1
$198K Buy
+1,058
New +$207K 0.01% 927

Other funds holding LLY

Maven Securities's LLY Position: Q2 2025 in Review

Maven Securities sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 4,370 shares — an estimated $3.4M sold.

Maven Securities first reported a position in LLY in Q1 2021 and held it in 13 quarters. The position peaked at $5.28M in Q1 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Maven Securities reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Maven Securities sold 4,370 Eli Lilly shares in Q2 2025, an estimated $3.4M.
  • Maven Securities first reported a position in Eli Lilly in Q1 2021 and held it in 13 quarters.
  • Maven Securities's Eli Lilly position peaked at $5.28M in Q1 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Maven Securities's 13F filing for Q2 2025, filed 14 Aug 2025.